Highlights from: The 45th Annual Meeting of the American Society of Clinical Oncology.
Cig Media Group LP
D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D000068258:Bevacizumab; D017024:Chemotherapy, Adjuvant; D003110:Colonic Neoplasms / Q000235:genetics / Q000473:pathology / Q000628:therapy; D005472:Fluorouracil / Q000627:therapeutic use; D052138:Genes, Neoplasm / Q000235:genetics; D006801:Humans; D002955:Leucovorin / Q000627:therapeutic use; D009364:Neoplasm Recurrence, Local / Q000235:genetics; D009367:Neoplasm Staging; D009944:Organoplatinum Compounds / Q000627:therapeutic use; D018714:Radiotherapy, Adjuvant
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D009944:Organoplatinum Compounds; D000068258:Bevacizumab; D002955:Leucovorin; D005472:Fluorouracil